A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : FDG-PET / fluorodeoxyglucose positron emission tomography

[Related PubMed/MEDLINE]
Total Number of Papers: 2180
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   FDG-PET  (>> Co-occurring Abbreviation)
Long Form:   fluorodeoxyglucose positron emission tomography
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
1  2020 A case of lymphangioleiomyomatosis with diffuse large B-cell lymphoma: Usefulness of FDG-PET. LAM
2  2020 A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis. BHL, IgG4-RD
3  2020 A double-blind placebo-controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design. ASL-MRI, CBF, HBOT, T2D
4  2020 Abscopal Regressions of Lymphoma After Involved-Site Radiation Therapy Confirmed by Positron Emission Tomography. CMR, FL, ISRT
5  2020 Alterations in the metabolic networks of temporal lobe epilepsy patients: A graph theoretical analysis using FDG-PET. HS, TLE
6  2020 Alzheimer's deterioration in intellectual and neurobiological staging supports the retrogenesis model: a double dissociation between verbal/non-verbal judgments and the left/right parieto-temporal glucose metabolism. A retrospective data analysis from the Tajiri Project. AD, CMRglc
7  2020 An application of generalized matrix learning vector quantization in neuroimaging. GMLVQ, PD, SSM/PCA
8  2020 Associations Between FDG PET and Expression of VEGF and Microvessel Density in Different Solid Tumors: A Meta-analysis. CI, MVD, VEGF
9  2020 Bipolar Disorder Among Patients Diagnosed With Frontotemporal Dementia. bvFTD
10  2020 Brain 18F-FDG-PET: Utility in the Diagnosis of Dementia and Epilepsy. ---
11  2020 Brain activity underlying American crow processing of encounters with dead conspecifics. ---
12  2020 Clinical symptoms and associated vascular imaging findings in Takayasu's arteritis compared to giant cell arteritis. GCA, MRA, TAK
13  2020 Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy. ADL, MMSE, MRI, PSP, UPDRS
14  2020 Combined tumor plus nontumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancer. CRT, EFS, ESCC, FFDM, LRC, OS
15  2020 Continuous infusion chemotherapy, radiotherapy, and FDG-PET are feasible during extracorporeal membrane oxygenation. ECMO
16  2020 Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis. EEG, MRI, NMDAR
17  2020 Dependence of fluorodeoxyglucose (FDG) uptake on cell cycle and dry mass: a single-cell study using a multi-modal radiography platform. FDG, PI
18  2020 Diagnostic Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Gastric Mesenchymal Tumors. FDG, GISTs
19  2020 Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation Therapy. CLI, FFP, FL, TNI, WFRT
20  2020 Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis. GCA, LVV, TA
21  2020 Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung Cancer. OS
22  2020 Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal Adenocarcinoma. NA, OS, PDAC
23  2020 Evidence and Considerations on Treatment of Small Size Merkel Cell Head and Neck Carcinoma. CT, SLNs
24  2020 Expression of Cellular Receptors in the Ischemic Hemisphere of Mice with Increased Glucose Uptake. UCCAO
25  2020 FDG-PET assessment and metabolic patterns in Lafora disease. LD
26  2020 FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis. CRLM, GLUT1, HIF-1alpha, PKM2, SUV
27  2020 Feasibility of Assessing Inflammation in Asymptomatic Abdominal Aortic Aneurysms With Integrated 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging. AAA, LGE, MRI, SUV
28  2020 Features and clinical impact of extra-cardiac lesions with 18F-fluorodeoxyglucose positron emission tomography in patients with suspected cardiac sarcoidosis. EMB
29  2020 Focal cortical dysplasia imaging discrepancies between MRI and FDG-PET: Unique association with temporal lobe location. FCD, MRI
30  2020 Genomic Signature of the Standardized Uptake Value in 18F-Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer. BRC, CI, HR, SUV
31  2020 Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype. DOI, GLUT1, HIF1a, OSCC
32  2020 Identification of a Pathogenic PSEN1 Ala285Val Mutation Associated with Early-Onset Alzheimer's Disease. AD, FBB-PET, PSEN1
33  2020 Imaging in Suspected Cardiac Sarcoidosis: A Diagnostic Challenge. CMR, CS, LV, TTE
34  2020 In-vivo signatures of neurodegeneration in isolated rapid eye movement sleep behaviour disorder. iRBD
35  2020 Influence of Hypertension on Longitudinal Changes in Brain Glucose Metabolism Was Modified by the APOE4 Allele Among Cognitively Normal Older Individuals. ADNI, APOE4, HTN
36  2020 Integrated strategy combining endobronchial ultrasound with positron emission tomography to diagnose peripheral pulmonary lesions. EBUS-TBLB, PPLs
37  2020 Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease. AD, CR
38  2020 Intranasal anti-caspase-1 therapy preserves myelin and glucose metabolism in a model of progressive multiple sclerosis. BMCs, CNS, MS, NAWM
39  2020 Is Paget Disease of Bone more Common in South India? Clinical Characteristics, Therapeutic Outcome and follow-up of 66 Patients from Tamil Nadu. PDB, SAP
40  2020 Is there any correlation between HPV and early radioresponse before brachytherapy in cervix uteri carcinoma? HPV, MRI
41  2020 Liver metastasis from papillary thyroid carcinoma treated by laparoscopic hepatectomy 43 years after resection of the primary tumor: a case report. PTC
42  2020 Management of FDG avid Benign Sinonasal Schneiderian Papilloma: A Case Report and Review of the Literature. CT, MRI
43  2020 Maturation of topological organization of brain networks in male adolescent rats: A longitudinal FDG-PET study. ---
44  2020 Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography. AD, CN, DLB
45  2020 MRI and FDG PET/CT Findings for Borderline Brenner Tumor of the Ovary: A Case Report and Literature Review. ADC, BT, DWI, MRI, SI, T2WI
46  2020 Multi-modal neuroimaging feature selection with consistent metric constraint for diagnosis of Alzheimer's disease. AD, ADNI, AUC, MCI, MCI-C, MCI-NC, MK-SVM, NC, VBM-MRI
47  2020 Multimodal neurometabolic investigation of the effects of zolpidem on leukoencephalopathy-related apathy. GABA, MRS
48  2020 Neural correlates of different behavioral response to transcranial direct current stimulation between patients in the unresponsive wakefulness syndrome and minimally conscious state. CMRgl, CRS-R, DLPFC, ERP, MCS, tDCS, UWS
49  2020 Nociception Coma Scale-Revised Allows to Identify Patients With Preserved Neural Basis for Pain Experience. DOC, NCS-R, UWS
50  2020 Novel Antineuronal Autoantibodies With Somatodendritic Staining Pattern in a Patient With Autoimmune Psychosis. CSF, EEG, MRI
51  2020 Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly. AD, BMI, CSF, FWE
52  2020 Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders. AD, MRI
53  2020 Parkinson Disease-Related Pattern of Glucose Metabolism Associated With the Potential for Motor Improvement After Deep Brain Stimulation. DBS, PD, SUVRs
54  2020 Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies. anti-GlyR, CBD, CSF, MRI, PSP, SPECT
55  2020 Pathogenic PSEN1 Thr119Ile Mutation in Two Korean Patients with Early-Onset Alzheimer's Disease. AD, EOAD, MRI, PET, PSEN1
56  2020 PD-1/PD-L1 negative schwannoma mimicking obstructive bronchial malignancy: A case report. ---
57  2020 Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer. MTD
58  2020 Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC). CT, MIBC, MRI
59  2020 Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment. BM, BMI, CK, DLBCL, HSCT, IPI
60  2020 Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer Therapy. ---
61  2020 Posterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer's Disease. AD, FTD, PCC, ROI
62  2020 Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study. AD, ADAS-cog, ADNI, AUC, BNA, MCI, MMSE, pMCI, RBF, sMCI, SVM
63  2020 Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning. AD, MRI
64  2020 Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy. CI, ESCC, HR, LI, nCRT
65  2020 Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas. CT, MRI
66  2020 Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX. BR, CA19-9, LA
67  2020 Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial. 5-PS, CI, EOT, HR, iPET, OS, PFS
68  2020 Psychiatric Manifestation of Anti-LGI1 Encephalitis. LGI1
69  2020 Quantifying brain metabolism from FDG-PET images into a probability of Alzheimer's dementia score. AD, SDAT
70  2020 Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics. CT, LPA
71  2020 Reevaluation of Astrocyte-Neuron Energy Metabolism with Astrocyte Volume Fraction Correction: Impact on Cellular Glucose Oxidation Rates, Glutamate-Glutamine Cycle Energetics, Glycogen Levels and Utilization Rates vs. Exercising Muscle, and Na+/K+ Pumping Rates. MRS
72  2020 Retrograde amnesia with transposition in the past: A neuropsychological and PET study of a case. RA, SMS
73  2020 Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any? GLM
74  2020 Role of FDG-PET/CT in children with fever of unknown origin. CT, FUO
75  2020 Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients. AD, OAA
76  2020 Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer. AUC, MTV, RMSE, SUV
77  2020 Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer. CT
78  2020 Speckle tracking echocardiography can predict subclinical myocardial involvement in patients with sarcoidosis: A meta-analysis. CI, CMR, CS, GCS, LV-GLS, MCE, SMD, STE
79  2020 Team Approach: Evaluation and Management of Low-Grade Cartilaginous Lesions. CT, MRI
80  2020 The PET Sandwich: Using Serial FDG-PET Scans with Interval Burst Suppression to Assess Ictal Components of Disease. cvEEG, IIC
81  2020 The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population. CT
82  2020 Three cases of follicular pancreatitis: association between radiological findings and pathological features. FP, SUV
83  2020 Timing of fluorodeoxyglucose positron emission tomography maximum standardized uptake value for diagnosis of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy. NSCLC, PFS, SBRT
84  2020 Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma. CytAct, ICB, LUAD
85  2020 Tumor Segmentation and Feature Extraction from Whole-Body FDG-PET/CT Using Cascaded 2D and 3D Convolutional Neural Networks. NHL, NSCLC
86  2020 Value of SUVmax for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma. OSCC
87  2020 Variability of clinical syndromes and cerebral glucose metabolism in symptomatic frontotemporal lobar degeneration associated with progranulin mutations. ---
88  2020 Well-differentiated fetal adenocarcinoma of the lung: positron emission tomography features and diagnostic difficulties in frozen section analysis-a case report. WDFA
89  2020 What Are the Results of Resection of Localized Dedifferentiated Liposarcomas in the Extremities? ALT, CDK4, DDLPS, PET/CT
90  2020 [18F-fluorodeoxyglucose-positron emission tomography imaging before and after treatment of chronic-phase chronic myeloid leukemia with tyrosine kinase inhibitors]. CML
91  2020 [Metachronous Pubic Bone Metastases from Synchronous Double Cancer with Prostate and Ascending Colon Cancers : A Case Report]. CA19-9, CEA, PSA
92  2019 18F-FDG-PET in Finnish patients with clinical suspicion of cardiac sarcoidosis: Female sex and history of atrioventricular block increase the prevalence of positive PET findings. CS
93  2019 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Treatment Efficacy and Clinical Outcome for Patients With Pancreatic Carcinoma: A Meta-analysis. HR
94  2019 A Nude Mouse Model of Orthotopic Liver Transplantation of Human Hepatocellular Carcinoma HCCLM3 Cell Xenografts and the Use of Imaging to Evaluate Tumor Progression. alpha-SMA, CEUS, HCC, US, VEGF
95  2019 Anti-N-methyl-D-aspartate Encephalitis Concomitantly with Tall-cell Variant Papillary Thyroid Carcinoma. NMDA
96  2019 Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance. HC, SNT
97  2019 Association of metabolic and genetic heterogeneity in head and neck squamous cell carcinoma with prognostic implications: integration of FDG PET and genomic analysis. GlycoS, HNSC, MATH
98  2019 Associations between GLUT expression and SUV values derived from FDG-PET in different tumors-A systematic review and meta analysis. GLUT, SUV
99  2019 Brain metabolic connectome classify mild cognitive impairment into Alzheimer's dementia. AD, MCI
100  2019 Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma. cHL, HSCT, PFS, R/R